Clinical Trial Update: Inectolizumab With Steroid Optimization in Newly Treated NMOSD [NA]

View source ↗

Summary

Clinical trial update indicates Inectolizumab with steroid optimization is being studied for newly treated neuromyelitis optica spectrum disorder, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• Inectolizumab

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Neuromyelitis Optica, Autoimmune Diseases | NA | Status: NOT_YET_RECRUITING